Circulating midkine in Crohnʼs disease: Clinical implications
Open Access
- 1 February 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 16 (2) , 208-215
Abstract
Background. A noninvasive marker facilitating differential diagnosis in Crohn's disease (CD) is sought after. Midkine is a heparin-binding growth factor of angiKeywords
This publication has 31 references indexed in Scilit:
- Midkine as a prognostic biomarker in oral squamous cell carcinomaBritish Journal of Cancer, 2008
- Midkine is involved in tubulointerstitial inflammation associated with diabetic nephropathyLaboratory Investigation, 2007
- Midkine expression in colorectal tumors: Correlation with Ki-67 labeling in sporadic, but not ulcerative colitis-associated onesPathology International, 2007
- Serum midkine depends on lymph node involvement and correlates with circulating VEGF-C in oesophageal squamous cell carcinomaBiomarkers, 2007
- Crohn’s Disease Activity Index and Vienna Classification – Is It Worthwhile to Calculate before Surgery?Digestive Surgery, 2006
- Increased expression of midkine in the rat colon during healing of experimental colitisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2006
- Angiogenesis as a Novel Component of Inflammatory Bowel Disease PathogenesisGastroenterology, 2006
- Differential gene and protein expression in abluminal sprouting and intraluminal splitting forms of angiogenesisClinical Science, 2006
- Midkine, a heparin‐binding growth factor, is fundamentally involved in the pathogenesis of rheumatoid arthritisArthritis & Rheumatism, 2004
- Role of chemokines and chemokine receptors in the gastrointestinal tractImmunology, 2002